ALBERT DAVID
Quarterly Results Analysis [Dec2024]
ALBERT DAVID Quarterly Results
Standalone | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 Audited |
Jun2023 UnAudited |
Mar2023 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹83 Cr | ₹98 Cr | ₹89 Cr | ₹89 Cr | ₹88 Cr | ₹93 Cr | ₹92 Cr | ₹81 Cr |
Expenses | ₹82 Cr | ₹92 Cr | ₹88 Cr | ₹79 Cr | ₹80 Cr | ₹77 Cr | ₹79 Cr | ₹72 Cr |
Operating Income | ₹1 Cr | ₹6 Cr | ₹1 Cr | ₹10 Cr | ₹8 Cr | ₹16 Cr | ₹13 Cr | ₹10 Cr |
Other Income | ₹-9 Cr | ₹21 Cr | ₹23 Cr | ₹10 Cr | ₹17 Cr | ₹12 Cr | ₹18 Cr | ₹0 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr |
Profit Before Tax | ₹-10 Cr | ₹25 Cr | ₹22 Cr | ₹18 Cr | ₹23 Cr | ₹27 Cr | ₹29 Cr | ₹7 Cr |
Profit After Tax | ₹-9 Cr | ₹18 Cr | ₹19 Cr | ₹13 Cr | ₹19 Cr | ₹20 Cr | ₹23 Cr | ₹4 Cr |
EPS | ₹-16.45 | ₹31.66 | ₹33.02 | ₹22.62 | ₹32.80 | ₹35.57 | ₹41.16 | ₹6.54 |
Industry Peers & Returns | 1W | 1M | 1Y |
ALBERT DAVID | -3.7% | -2.2% | -24.1% |
SUN PHARMACEUTICAL INDUSTRIES | -3.9% | 3% | 7.9% |
DIVIS LABORATORIES | -5% | -1.1% | 71.6% |
CIPLA | -4.4% | 0.2% | -1.7% |
TORRENT PHARMACEUTICALS | -1.6% | 6.5% | 26.2% |
DR REDDYS LABORATORIES | -2.4% | 2.4% | -5.4% |
MANKIND PHARMA | 2.4% | 7.1% | 3.9% |
ZYDUS LIFESCIENCES | -3.3% | -1% | -11.4% |
LUPIN | -5.4% | 3.4% | 26.8% |
ALBERT DAVID Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -15.60 % |
Y-o-Y | -5.89 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹83 Cr | -15.60 | |
Sep2024 | ₹98 Cr | 10.16 | |
Jun2024 | ₹89 Cr | 0.33 | |
Mar2024 | ₹89 Cr | 0.88 | |
Dec2023 | ₹88 Cr | -5.25 | |
Sep2023 | ₹93 Cr | 1.34 | |
Jun2023 | ₹92 Cr | 12.93 | |
Mar2023 | ₹81 Cr | - |
ALBERT DAVID Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -89.22 % |
Y-o-Y | -91.97 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹1 Cr | -89.22 | |
Sep2024 | ₹6 Cr | 609.46 | |
Jun2024 | ₹1 Cr | -90.84 | |
Mar2024 | ₹10 Cr | 14.56 | |
Dec2023 | ₹8 Cr | -47.68 | |
Sep2023 | ₹16 Cr | 22.91 | |
Jun2023 | ₹13 Cr | 35.41 | |
Mar2023 | ₹10 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -87.18 % |
Y-o-Y | -91.44 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 0.81% | -87.18 | |
Sep2024 | 6.32% | 544.90 | |
Jun2024 | 0.98% | -90.88 | |
Mar2024 | 10.75% | 13.64 | |
Dec2023 | 9.46% | -44.81 | |
Sep2023 | 17.14% | 21.30 | |
Jun2023 | 14.13% | 19.95 | |
Mar2023 | 11.78% | - |
ALBERT DAVID Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹-9 Cr | Negative | |
Sep2024 | ₹18 Cr | -4.10 | |
Jun2024 | ₹19 Cr | 45.94 | |
Mar2024 | ₹13 Cr | -31.02 | |
Dec2023 | ₹19 Cr | -7.79 | |
Sep2023 | ₹20 Cr | -13.58 | |
Jun2023 | ₹23 Cr | 529.08 | |
Mar2023 | ₹4 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | -11.3 % | Negative | |
Sep2024 | 18.36 % | -12.94 | |
Jun2024 | 21.09 % | 45.45 | |
Mar2024 | 14.5 % | -31.60 | |
Dec2023 | 21.2 % | -2.71 | |
Sep2023 | 21.79 % | -14.72 | |
Jun2023 | 25.55 % | 456.64 | |
Mar2023 | 4.59 % | - |
ALBERT DAVID Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹-16.45 | Negative | |
Sep2024 | ₹31.66 | -4.12 | |
Jun2024 | ₹33.02 | 45.98 | |
Mar2024 | ₹22.62 | -31.04 | |
Dec2023 | ₹32.8 | -7.79 | |
Sep2023 | ₹35.57 | -13.58 | |
Jun2023 | ₹41.16 | 529.36 | |
Mar2023 | ₹6.54 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD